Hiv And Aids Support

Health Condition

HIV and AIDS Support

  • Boxwood

    Supplementing with boxwood appears to support CD4 cell counts.

    Dose:

    990 mg per day of an extract of the leaves and stems
    Boxwood
    ×
     

    One double-blind trial has found that 990 mg per day of an extract of the leaves and stems of boxwood (Buxus sempervirens) could delay the progression of HIV infection (as measured by a decline in CD4 cell counts).4 No adverse effects directly attributable to the extract were reported. Taking twice the amount of boxwood extract did not lead to further benefits and may have actually decreased its usefulness.

  • DHEA

    Large amounts of supplemental DHEA may alleviate fatigue in HIV-positive people.

    Dose:

    200 to 500 mg daily
    DHEA
    ×
     

    A deficient level of dehydroepiandrosterone sulfate (DHEAS) in the blood is associated with poor outcomes in people with HIV.5 Large amounts of supplemental DHEA (dehydroepiandrosterone) may alleviate fatigue and depression in HIV-positive men and women. In a preliminary trial, men and women with HIV infection took 200–500 mg of DHEA per day for eight weeks.6 All participants initially had both low mood and low energy. After eight weeks of DHEA supplementation, 72% of the participants reported their mood to be “much improved” or “very much improved,” and 81% reported having significant improvements in energy level. DHEA supplementation had no effect on CD4 cell (helper T-cell) counts or testosterone levels.

  • Licorice

    Licorice inhibits HIV reproduction in test tubes, supplementing with it may be safe and effective for long-term treatment of HIV infection.

    Dose:

    Refer to label instructions
    Licorice
    ×
     

    Licorice has shown the ability to inhibit reproduction of HIV in test tubes.7 Clinical trials have shown that injections of glycyrrhizin (isolated from licorice) may have a beneficial effect on AIDS.8 There is preliminary evidence that orally administered licorice also may be safe and effective for long-term treatment of HIV infection.9 Amounts of licorice or glycyrrhizin used for treating HIV-positive people warrant monitoring by a physician, because long-term use of these substances can cause high blood pressure, potassium depletion, or other problems. Approximately 2 grams of licorice root should be taken per day in capsules or as tea. Deglycyrrhizinated licorice (DGL) will not inhibit HIV.

  • Multivitamin

    Taking a daily multivitamin supplement may prevent common deficiencies associated with HIV and AIDS.

    Dose:

    Follow label directions
    Multivitamin
    ×

    Because people with HIV infection or AIDS often have multiple nutritional deficiencies, a broad-spectrum nutritional supplement may be beneficial. In one trial, HIV-positive men who took a multivitamin-mineral supplement had slower onset of AIDS, compared with men who did not take a supplement.10Use of a multivitamin by pregnant and breast-feeding Tanzanian women with HIV did not affect the risk of transmission of HIV from mother to child, either in utero, during birth, or from breast-feeding.11

    The effect of multivitamins on people with HIV may be influenced by whether or not they are receiving modern medical therapy, known as highly active antiretroviral therapy (HAART). Studies conducted before HAART therapies were used showed that high-dose micronutrient supplements improved immune function, slowed disease progression, and decreased mortality. However, a recent double-blind trial found that, in people using HAART, the use of vitamins in amounts well above the Recommended Dietary Allowance (RDA), when compared with RDA amounts, had no effect on disease progression, but may have increased stress on the liver.12 People who are receiving HAART therapy should consult their doctor regarding the appropriate amounts of vitamins to take.

  • N-Acetyl Cysteine

    Supplementing with NAC may slow the decline in immune function.

    Dose:

    800 mg daily
    N-Acetyl Cysteine
    ×
     

    The amino acid NAC (N-acetyl cysteine) has been shown to inhibit the replication of HIV in test tube studies.13 In a double-blind trial, supplementing with 800 mg per day of NAC slowed the rate of decline in immune function in people with HIV infection. NAC also promotes the synthesis of glutathione, a naturally-occurring antioxidant that is believed to be protective in people with HIV infection and AIDS.14

  • Saccharomyces boulardii

    In one trial, Saccharomyces boulardii helped stop diarrhea in HIV-positive people.

    Dose:

    Take under medical supervision: 1 gram three times per day of Saccharomyces boulardii for diarrhea
    Saccharomyces boulardii
    ×
     

    In a double-blind trial, the non-disease-causing yeast Saccharomyces boulardii (1 gram three times per day) helped stop diarrhea in HIV-positive people.15 However, people with severely compromised immune function have been reported to develop yeast infections in the bloodstream after consuming some yeast organisms that are benign for healthy people.16,17 For that reason, people with HIV infection who wish to take Saccharomyces boulardii, brewer’s yeast (Saccharomyces cerevisiae), or other live organisms should first consult a doctor.

  • Selenium

    Supplementing with selenium may result in fewer infections, a healthier appetite, and other benefits.

    Dose:

    Take under medical supervision: 400 mcg daily
    Selenium
    ×

    Selenium deficiency is an independent factor associated with high mortality among HIV-positive people.18 HIV-positive people who took selenium supplements experienced fewer infections, better intestinal function, improved appetite, and improved heart function (which had been impaired by the disease) than those who did not take the supplements.19 The usual amount of selenium taken was 400 mcg per day.

    Selenium deficiency has been found more often in people with HIV-related cardiomyopathy (heart abnormalities) than in those with HIV and normal heart function.20 People with HIV-related cardiomyopathy may benefit from selenium supplementation. In a small preliminary trial, people with AIDS and cardiomyopathy, 80% of whom were found to be deficient in selenium, were given 800 mcg of selenium per day for 15 days, followed by 400 mcg per day for eight days. Improvements in heart function were noted after selenium supplementation.21 People wishing to supplement with more than 200 mcg of selenium per day should be monitored by a doctor.

     
  • Zinc

    Zinc levels are frequently low in people with HIV infection. Zinc supplements have been shown to reduce the number of infections in people with AIDS.

    Dose:

    12 to 45 mg daily
    Zinc
    ×
     

    Blood levels of both zinc22 and selenium23 are frequently low in people with HIV infection. Zinc supplements (45 mg per day) have been shown to reduce the number of infections in people with AIDS.24 Zinc supplementation (12 mg per day for women, 15 mg per day for men) also slowed the decline in immune function in HIV-infected adults with low blood levels of zinc.25

  • Andrographis

    A trial of isolated andrographolides, found in andrographis, showed that they decreased viral load and increased CD4 lymphocyte levels in people with HIV infection.

    Dose:

    Refer to label instructions
    Andrographis
    ×
     

    A preliminary trial of isolated andrographolides, found in andrographis, determined that while they decreased viral load and increased CD4 lymphocyte levels in people with HIV infection, they also caused potentially serious liver problems and changes in taste in many of the participants.26 It is unknown whether andrographis directly killed HIV or was having an immune-strengthening effect in this trial.

  • Asian Ginseng

    One study found that steamed then dried Asian ginseng had beneficial effects in people infected with HIV and increased the effectiveness of the anti-HIV drug AZT.

    Dose:

    Refer to label instructions
    Asian Ginseng
    ×
     

    Immune-modulating plants that could theoretically be beneficial for people with HIV infection include Asian ginseng, eleuthero, and the medicinal mushrooms shiitake and reishi. One preliminary study found that steamed then dried Asian ginseng (also known as red ginseng) had beneficial effects in people infected with HIV, and increased the effectiveness of the anti-HIV drug, AZT.27 This supports the idea that immuno-modulating herbs could benefit people with HIV infection, though more research is needed.

  • Beta-Carotene

    Beta-carotene levels have been found to be low in HIV-positive people, supplementing with it may be beneficial.

    Dose:

    Refer to label instructions
    Beta-Carotene
    ×

    Caution: Synthetic beta-carotene has been linked to increased risk of lung cancer in smokers. Until more is known, smokers should avoid all beta-carotene supplements.

    Beta-carotene levels have been found to be low in HIV-positive people, even in those without symptoms.28 However, trials on the effect of beta-carotene supplements have produced conflicting results. In one double-blind trial, supplementing with 300,000 IU per day of beta-carotene significantly increased the number of CD4+ cells in people with HIV infection.29 In a second double-blind study, supplementing with natural mixed carotenoids equivalent to 120,000 IU of beta-carotene per day significantly prolonged survival times in adults with advanced AIDS who were also receiving conventional therapy and a multivitamin.30 In another trial, however, 300,000 IU per day of beta-carotene had no effect on CD4+ cell counts or various other measures of immune function in HIV-infected people.31

  • Cat’s Claw

    Cat’s claw is an immuno-modulating herb. Standardized extracts of it have been shown to help prevent CD4 cell counts from dropping and to prevent opportunistic infections.

    Dose:

    Refer to label instructions
    Cat’s Claw
    ×
     

    Cat’s claw is another immuno-modulating herb. Standardized extracts of cat’s claw have been tested in small, preliminary trials in people infected with HIV, showing some benefits in preventing CD4 cell counts from dropping and in preventing opportunistic infections.32,33 Further study is needed to determine whether cat’s claw is truly beneficial for people with HIV infection or AIDS.

  • Coenzyme Q10

    In one trial, people with HIV who took CoQ10 experienced no further infections for up to seven months, and counts of infection-fighting white blood cells improved in some cases.

    Dose:

    Refer to label instructions
    Coenzyme Q10
    ×
     

    Blood levels of coenzyme Q10 (CoQ10) were also found to be low in people with HIV infection or AIDS. In a small preliminary trial, people with HIV infection took 200 mg per day of CoQ10. Eighty-three percent of these people experienced no further infections for up to seven months, and the counts of infection-fighting white blood cells improved in three cases.34

  • Echinacea

    Supplementing with echinacea may increase immune activity against HIV.

    Dose:

    Refer to label instructions
    Echinacea
    ×
     

    A controversy has surrounded the use of echinacea in people infected with HIV. Test tube studies initially showed that echinacea’s polysaccharides could increase levels of a substance that might stimulate HIV to spread.35 However, these results have not been shown to occur when echinacea is taken orally by humans.36 In fact, one double-blind trial found that Echinacea angustifolia root (1 gram three times per day by mouth) greatly increased immune activity against HIV, while placebo had no effect.37 Further studies are needed to determine the safety of using echinacea in HIV-positive people.

  • Eleuthero

    Eleuthero is an immune-modulating plant that may be beneficial for people with HIV infection.

    Dose:

    Refer to label instructions
    Eleuthero
    ×
     

    Immune-modulating plants that could theoretically be beneficial for people with HIV infection include Asian ginseng, eleuthero, and the medicinal mushrooms shiitake and reishi. One preliminary study found that steamed then dried Asian ginseng (also known as red ginseng) had beneficial effects in people infected with HIV, and increased the effectiveness of the anti-HIV drug, AZT.38 This supports the idea that immuno-modulating herbs could benefit people with HIV infection, though more research is needed.

  • Folic Acid

    Low folic acid levels are also common in HIV-positive people, supplementing may help correct a deficiency.

    Dose:

    Refer to label instructions
    Folic Acid
    ×
     

    In HIV-positive people with B-vitamin deficiency, the use of B-complex vitamin supplements appears to delay progression to and death from AIDS.39 Thiamine (vitamin B1) deficiency has been identified in nearly one-quarter of people with AIDS.40 It has been suggested that a thiamine deficiency may contribute to some of the neurological abnormalities that are associated with AIDS. Vitamin B6 deficiency was found in more than one-third of HIV-positive men; vitamin B6 deficiency was associated with decreased immune function in this group.41 In a population study of HIV-positive people, intake of vitamin B6 at more than twice the recommended dietary allowance (RDA is 2 mg per day for men and 1.6 mg per day for women) was associated with improved survival.42 Low blood levels of folic acid and vitamin B12 are also common in HIV-positive people.43

  • Garlic

    Garlic may help combat opportunistic infections. In one trial, an aged garlic extract reduced the number of infections and relieved diarrhea in a group of patients with AIDS.

    Dose:

    Refer to label instructions
    Garlic
    ×
     

    Garlic may assist in combating opportunistic infections. In one trial, administration of an aged garlic extract reduced the number of infections and relieved diarrhea in a group of patients with AIDS.44 Garlic’s active constituents have also been shown to kill HIV in the test tube, though these results have not been confirmed in human trials.45

  • Glutamine

    The amino acid glutamine is needed for the synthesis of glutathione, an important antioxidant that is frequently depleted in people with HIV and AIDS.

    Dose:

    Refer to label instructions
    Glutamine
    ×

    The amino acidglutamine is needed for the synthesis of glutathione, an important antioxidant within cells that is frequently depleted in people with HIV and AIDS.46 In well-nourished people, the body usually manufactures enough glutamine to prevent a deficiency. However, people with HIV or AIDS are often malnourished and may be deficient in glutamine.47 In such people, glutamine supplementation may be needed, along with NAC, to maintain adequate levels of glutathione. It is not known how much glutamine is needed for that purpose; however, in other trials, 4–8 grams of glutamine per day was used.48 In a double-blind trial, massive amounts of glutamine (40 grams per day) in combination with several antioxidants (27,000 IU per day of beta-carotene; 800 mg per day of vitamin C; 280 mcg per day of selenium; 500 IU per day of vitamin E) were given for 12 weeks to AIDS patients experiencing problems maintaining normal weight.49 Those who took the glutamine-antioxidant combination experienced significant gains in body weight compared with those taking placebo. Larger trials are needed to determine the possible benefits of this nutrient combination on reducing opportunistic infections and long-term mortality.

  • Iron

    Iron deficiency is often present in HIV-positive children. Supplementing with it, under a doctor's supervision, may support immune function.

    Dose:

    Refer to label instructions
    Iron
    ×
     

    Iron deficiency is often present in HIV-positive children.50 While iron is necessary for normal immune function, iron deficiency also appears to protect against certain bacterial infections.51 Iron supplementation could therefore increase the severity of bacterial infections in people with AIDS. For that reason, people with HIV infection or AIDS should consult a doctor before supplementing with iron.

  • Maitake

    Maitake mushrooms contain immuno-modulating polysaccharides (including beta-D-glucan) that may be supportive for HIV infection.

    Dose:

    Refer to label instructions
    Maitake
    ×
     

    Maitake mushrooms, which are currently being studied, contain immuno-modulating polysaccharides (including beta-D-glucan) that may be supportive for HIV infection.52,53

  • Methionine

    One trial found that methionine may improve memory recall in people with AIDS-related nervous system degeneration.

    Dose:

    Refer to label instructions
    Methionine
    ×
     

    People with AIDS have low levels of methionine. Some researchers suggest that these low methionine levels may explain some aspects of the disease process,54,55,56 especially the deterioration that occurs in the nervous system and is responsible for symptoms such as dementia.57,58 A preliminary trial found that methionine (6 grams per day) may improve memory recall in people with AIDS-related nervous system degeneration.59

    In a preliminary trial, a thymus extract known as Thymomodulin® improved several immune parameters among people with early HIV infection, including an increase in the number of T-helper cells.60

  • Mistletoe

    Mistletoe injections into the skin have shown beneficial effects in people with HIV.

    Dose:

    Refer to label instructions
    Mistletoe
    ×
     

    Preliminary human clinical trials of European mistletoe injections into the skin have shown beneficial effects.61,62 Oral mistletoe is very unlikely to have the same effects as injected mistletoe. Injectable mistletoe should only be used under the supervision of a qualified healthcare professional.

  • Reishi

    Reishi is medicinal mushroom with immune-modulating effects that may be beneficial for people with HIV infection.

    Dose:

    Refer to label instructions
    Reishi
    ×
     

    Immune-modulating plants that could theoretically be beneficial for people with HIV infection include Asian ginseng, eleuthero, and the medicinal mushrooms shiitake and reishi. One preliminary study found that steamed then dried Asian ginseng (also known as red ginseng) had beneficial effects in people infected with HIV, and increased the effectiveness of the anti-HIV drug, AZT.63 This supports the idea that immuno-modulating herbs could benefit people with HIV infection, though more research is needed.

  • Shiitake

    Shiitake is medicinal mushroom immune-modulating effects that may be beneficial for people with HIV infection.

    Dose:

    Refer to label instructions
    Shiitake
    ×
     

    Immune-modulating plants that could theoretically be beneficial for people with HIV infection include Asian ginseng, eleuthero, and the medicinal mushrooms shiitake and reishi. One preliminary study found that steamed then dried Asian ginseng (also known as red ginseng) had beneficial effects in people infected with HIV, and increased the effectiveness of the anti-HIV drug, AZT.64 This supports the idea that immuno-modulating herbs could benefit people with HIV infection, though more research is needed.

  • Sho-Saiko-To (Bupleurum, Peony, Pinellia, Cassia, Ginger, Jujube, Asian Ginseng, Asian Scullcap, and Licorice)

    The herbal formula sho-saiko-to has been shown to have beneficial immune effects on white blood cells in people infected with HIV.

    Dose:

    Refer to label instructions
    Sho-Saiko-To (Bupleurum, Peony, Pinellia, Cassia, Ginger, Jujube, Asian Ginseng, Asian Scullcap, and Licorice)
    ×
     

    The Chinese herb bupleurum, as part of the herbal formula sho-saiko-to, has been shown to have beneficial immune effects on white blood cells taken from people infected with HIV.65 Sho-saiko-to has also been shown to improve the efficacy of the anti-HIV drug lamivudine in the test tube.66 One preliminary study found that 7 of 13 people with HIV given sho-saiko-to had improvements in immune function.67 Double-blind trials are needed to determine whether bupleurum or sho-saiko-to might benefit people with HIV infection or AIDS. Other herbs in sho-saiko-to have also been shown to have anti-HIV activity in the test tube, most notably Asian scullcap.68 Therefore studies on sho-saiko-to cannot be taken to mean that bupleurum is the only active herb involved. The other ingredients are peony root, pinellia root, cassia bark, ginger root, jujube fruit, Asian ginseng root, Asian scullcap root, and licorice root.

  • St. John’s Wort

    A preliminary trial found that people infected with HIV who took hypericin, a constituent from St. John’s wort, had some improvements in CD4+ cell counts.

    Dose:

    Refer to label instructions
    St. John’s Wort
    ×

    Caution: It is likely that there are many drug interactions with St. John's wort that have not yet been identified. St. John's wort stimulates a drug-metabolizing enzyme (cytochrome P450 3A4) that metabolizes at least 50% of the drugs on the market.69 Therefore, it could potentially cause a number of drug interactions that have not yet been reported. People taking any medication should consult with a doctor or pharmacist before taking St. John's wort.

    A constituent from St. John’s wort known as hypericin has been extensively studied as a potential way to kill HIV. A preliminary trial found that people infected with HIV who took 1 mg of hypericin per day by mouth had some improvements in CD4+ cell counts, particularly if they had not previously used AZT.70 A small number of people developed signs of mild liver damage in this study. Another much longer preliminary trial used injectable extracts of St. John’s wort twice a week combined with three tablets of a standardized extract of St. John’s wort taken three times per day by mouth. This study found not only improvements in CD4+ counts but only 2 of 16 participants developed opportunistic infections.71 No liver damage or any other side effects were noted in this trial. In a later study, much higher amounts of injectable or oral hypericin (0.25 mg/kg body weight or higher) led to serious side effects, primarily extreme sensitivity to sunlight.72 At this point, it is unlikely that isolated hypericin or supplements of St. John’s wort extract supplying very high levels of hypericin can safely be used by people with HIV infection, particularly given St. John’s wort’s many drug interactions.
  • Tea Tree

    A 5% solution of tea tree oil has been shown to eliminate oral thrush in people with AIDS, according to one trial.

    Dose:

    Refer to label instructions
    Tea Tree
    ×
     

    A 5% solution of tea tree oil has been shown to eliminate oral thrush in people with AIDS, according to one preliminary trial.73 The volunteers in the study swished 15 ml of the solution in their mouths four times per day and then spit it out. This may cause mild burning for a short period of time after use.

  • Thymus Extracts

    In one trial, a thymus extract known as Thymomodulin improved several immune parameters among people with early HIV infection, including an increase in T-helper cells.

    Dose:

    Refer to label instructions
    Thymus Extracts
    ×
     

    In a preliminary trial, a thymus extract known as Thymomodulin improved several immune parameters among people with early HIV infection, including an increase in the number of T-helper cells.74

  • Turmeric (Curcumin)

    Turmeric may be a useful herb with immune effects in people infected with HIV. One trial found that curcumin, turmeric’s main active compound, helped improve CD4+ cell counts.

    Dose:

    Refer to label instructions
    Turmeric (Curcumin)
    ×
     

    Turmeric may be another useful herb with immune effects in people infected with HIV. One preliminary trial found that curcumin, the main active compound in turmeric, helped improve CD4+ cell counts.75 The amount used in this study was 1 gram three times per day by mouth. These results differed from those found in a second preliminary trial using 4.8 or 2.7 grams of curcumin daily. In that study, there was no apparent effect of curcumin on HIV replication rates.76

  • Vitamin A

    Vitamin A deficiency is common in people with HIV infection, and low levels of the vitamin are associated with greater disease severity. Ask your doctor if vitamin A is right for you.

    Dose:

    Refer to label instructions
    Vitamin A
    ×
     

    Vitamin A deficiency appears to be very common in people with HIV infection. Low blood levels of vitamin A are associated with greater disease severity77 and increased transmission of the virus from a pregnant mother to her infant.78 However, in preliminary 79 and double-blind80,81 trials, supplementation with vitamin A failed to reduce the overall mother-to-child transmission of HIV. HIV-positive women who took 5,000 IU per day of vitamin A (as retinyl palmitate) and 50,000 IU per day of beta-carotene during the third trimester (13 weeks) of pregnancy, plus an additional single amount of 200,000 IU of vitamin A at delivery, had the same rate of transmission of HIV to their infants as those who did not take the supplement. However, lower rates of illness have been observed in the children of HIV-positive mothers when the children were supplemented with 50,000–200,000 IU of vitamin A every two to three months.82

    Little research has explored whether vitamin A supplements are helpful at halting disease progression. HIV-positive children given two consecutive oral supplements of vitamin A (200,000 IU in a gelcap) in the two days following influenza vaccinations had a modest but significant decrease in viral load.83 In one trial, giving people an extremely high (300,000 IU) amount of vitamin A one time only did not improve short-term measures of immunity in women with HIV.84

  • Vitamin B1

    People with AIDS often have thiamine (vitamin B1) deficiency, which may contribute to some neurological abnormalities, supplementing with the vitamin may help.

    Dose:

    Refer to label instructions
    Vitamin B1
    ×
     

    In HIV-positive people with B-vitamin deficiency, the use of B-complex vitamin supplements appears to delay progression to and death from AIDS.85 Thiamine (vitamin B1) deficiency has been identified in nearly one-quarter of people with AIDS.86 It has been suggested that a thiamine deficiency may contribute to some of the neurological abnormalities that are associated with AIDS. Vitamin B6 deficiency was found in more than one-third of HIV-positive men; vitamin B6 deficiency was associated with decreased immune function in this group.87 In a population study of HIV-positive people, intake of vitamin B6 at more than twice the recommended dietary allowance (RDA is 2 mg per day for men and 1.6 mg per day for women) was associated with improved survival.88 Low blood levels of folic acid and vitamin B12 are also common in HIV-positive people.89

  • Vitamin B12

    In HIV-positive people with B-vitamin deficiency, B vitamins appear to delay progression to and death from AIDS.

    Dose:

    Refer to label instructions
    Vitamin B12
    ×
     

    In HIV-positive people with B-vitamin deficiency, the use of B-complex vitamin supplements appears to delay progression to and death from AIDS.90 Thiamine (vitamin B1) deficiency has been identified in nearly one-quarter of people with AIDS.91 It has been suggested that a thiamine deficiency may contribute to some of the neurological abnormalities that are associated with AIDS. Vitamin B6 deficiency was found in more than one-third of HIV-positive men; vitamin B6 deficiency was associated with decreased immune function in this group.92 In a population study of HIV-positive people, intake of vitamin B6 at more than twice the recommended dietary allowance (RDA is 2 mg per day for men and 1.6 mg per day for women) was associated with improved survival.93 Low blood levels of folic acid and vitamin B12 are also common in HIV-positive people.94

  • Vitamin B3 (Niacin)

    Vitamin B3 may play a role in HIV prevention and treatment. A form of vitamin B3 (niacinamide) has been shown to inhibit HIV in test tube studies.

    Dose:

    Refer to label instructions
    Vitamin B3 (Niacin)
    ×
     

    Preliminary observations suggest a possible role for vitamin B3 in HIV prevention and treatment.95 A form of vitamin B3 (niacinamide) has been shown to inhibit HIV in test tube studies.96 However, no published data have shown vitamin B3 to inhibit HIV in animals or in people. One study did show that HIV-positive people who consume more than 64 mg of vitamin B3 per day have a decreased risk of progression to AIDS or AIDS-related death.97,97 Clinical trials in humans are required to validate these preliminary observations.

  • Vitamin B6

    Vitamin B6 deficiency was found in more than one-third of HIV-positive men, deficiency was associated with decreased immune function in this group. Supplementing with the vitamin may improve survival rate.

    Dose:

    Refer to label instructions
    Vitamin B6
    ×
     

    In HIV-positive people with B-vitamin deficiency, the use of B-complex vitamin supplements appears to delay progression to and death from AIDS.98 Thiamine (vitamin B1) deficiency has been identified in nearly one-quarter of people with AIDS.99 It has been suggested that a thiamine deficiency may contribute to some of the neurological abnormalities that are associated with AIDS. Vitamin B6 deficiency was found in more than one-third of HIV-positive men; vitamin B6 deficiency was associated with decreased immune function in this group.100 In a population study of HIV-positive people, intake of vitamin B6 at more than twice the recommended dietary allowance (RDA is 2 mg per day for men and 1.6 mg per day for women) was associated with improved survival.101 Low blood levels of folic acid and vitamin B12 are also common in HIV-positive people.102

  • Vitamin E

    In test-tube studies, vitamin E improved the effectiveness of the anti-HIV drug zidovudine (AZT) while reducing its toxicity.

    Dose:

    Refer to label instructions
    Vitamin E
    ×
     

    In test-tube studies, vitamin E improved the effectiveness of the anti-HIV drug zidovudine (AZT) while reducing its toxicity.103Similarly, animal research suggests that zinc and NAC supplementation may protect against AZT toxicity.104 It is not known whether oral supplementation with these nutrients would have similar effects in people taking AZT.

  • Whey Protein

    Whey protein is rich in the amino acid cysteine, which the body uses to make glutathione, an important antioxidant. Supplementing with it may improve immune function.

    Dose:

    Refer to label instructions
    Whey Protein
    ×
     

    Whey protein is rich in the amino acid cysteine, which the body uses to make glutathione, an important antioxidant. A double-blind trial showed that 45 grams per day of whey protein increased blood glutathione levels in a group of HIV-infected people.105 Test tube106 and animal107 studies suggest that whey protein may improve some aspects of immune function.

What Are Star Ratings
×
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.

References

1. The Group for the Scientific Reappraisal of the HIV/AIDS Hypothesis. AIDS Proposal. Science 1995;267:945-6.

2. Duesberg PH. Inventing the AIDS Virus. Washington, DC: Regnery Publishing, Inc., 1996.

3. Maggiore C, Mullis K. What if everything you thought you knew about AIDS was wrong? Studio City, CA: American Foundation for AIDS Alternatives, 2000.

4. Durant J, Chantre Ph, Gonzalez G, et al. Efficacy and safety of Buxus sempervirens L. preparations (SPV30) in HIV-infected asymptomatic patients: a multicentre, randomized, double-blind, placebo-controlled trial. Phytomedicine 1998;5(1):1-10.

5. Ferrando SJ, Rabkin JG, Poretsky L. Dehydroepiandrosterone sulfate (DHEAS) and testosterone: relation to HIV illness stage and progression over one year. J Acquir Immune Defic Syndr 1999;22:146-54.

6. Rabkin JG, Ferrando SJ, Wagner GJ, Rabkin R. DHEA treatment for HIV + patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology 2000;25:53-68.

7. Ito M, Sato A, Hirabayashi K, et al. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). Antivir Res 1988;10:289-98.

8. Hattori I, Ikematsu S, Koito A, et al. Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS. Antivir Res 1989;11:255-62.

9. Ikegami N, Akatani K, Imai M, et al. Prophylactic effect of long-term oral administration of glycyrrhizin on AIDS development of asymptomatic patients. Int Conf AIDS 1993;9:234 [abstract PO-A25-0596].

10. Ince S. Vitamin supplements may help delay onset of AIDS. Med Tribune 1993;9:18.

11. Fawzi WW, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Defic Syndr 2000;23:246-54.

12. Isanaka S, Mugusi F, Hawkins C, et al. Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial. JAMA 2012;308:1535-44.

13. Roederer M, Staal FJ, Raju PA, et al. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci 1990;87:4884-8.

14. Herzenberg LA, De Rosa SC, Dubs JG, et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci 1997;94:1967-72.

15. Blehaut H, Saint-Marc T, Touraine J. Double blind trial of Saccharomyces boulardii in AIDS-related diarrhea. International Conference on AIDS/Third STD World Congress, 1992, Abstract #2120, July 19-24.

16. Eng RHK, Drehmel R, Smith SM, Goldstein EJC. Saccharomyces cerevisiae infection in man. Sabouraudia: J Med Vet Mycol 1984;22:403-7.

17. Bassetti S, Frei R, Zimmerli W. Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii. Am J Med 1998;105:71-2.

18. Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:370-4.

19. Olmsted L, Schrauzer GN, Flores-Arce M, Dowd J. Selenium supplementation of symptomatic human immunodeficiency virus infected patients. Biol Trace Elem Res 1989;25:89-96.

20. Chariot P, Perchet H, Monnet I. Dilated cardiomyopathy in HIV-infected patients [letter; comment]. N Engl J Med 1999;340:732 (discussion 733-5).

21. Zazzo JF, Lafont A, Darwiche E, et al. Is non-obstructive myocardiopathy (NOMC) in AIDS selenium-deficiency related? In: Neve J, Favier A, eds. Selenium in biology and medicine. W. DeGruyter & Co.: Berlin New York, 1988, 281-2.

22. Fabris N, Mocchegiani E, Galli M, et al. AIDS, zinc deficiency, and thymic hormone failure. JAMA 1988;259:839-40.

23. Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Interact 1994;91:181-6.

24. Mocchegiani E, Veccia S, Ancarani F, et al. Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS. Int J Immunopharmacol 1995;17:719-27.

25. Baum MK, Lai S, Sales S, et al. Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults. Clin Infect Dis 2010;50:1653-60.

26. Miller S. Synopsis of PN355 Androvir study. Unpublished study. Seattle: Bastyr University, 1997.

27. Cho YK, Kim Y, Choi M, et al. The effect of red ginseng and zidovudine on HIV patients. Int Conf AIDS 1994;10:215 [abstract no. PB0289].

28. Sappey C, Leclercq P, Coudray C, et al. Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene deficiency. Clin Chim Acta 1994;230:35-42.

29. Coodley GO, Nelson HD, Loveless MO, Folk C. Beta-carotene in HIV infection. J Acquir Immune Defic Syndr 1993;6:272-6.

30. Austin J, Singhal N, Voigt R, et al. A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome. Eur J Clin Nutr 2006;60:1266-76.

31. Coodley GO, Coodley MK, Lusk R, et al. Beta-carotene in HIV infection: an extended evaluation. AIDS 1996;10:967-73.

32. Keplinger UM. Influence of Krallendorn extract on retroviral infection. Zürcher AIDS Kongress Zurich, Switzerland, Oct 16-7, 1992 [abstract in German].

33. Keplinger UM. Therapy of HIV-infected individuals in the pathological categories CDC A1 and CDC B2 with a preparation containing IMM-207. IV. Österreichischer AIDS-Kongress, Vienna, Austria, Sept 17-8, 1993, 45 [abstract].

34. Folkers K, Langsjoen P, Nara Y, et al. Biochemical deficiencies of coenzyme Q10 in HIV-infection and exploratory treatment. Biochem Biophys Res Commun 1988;153:888-96.

35. Luettig B, Steinmuller C, Gifford GE, et al. Macrocytic activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J Natl Cancer Inst 1989;81:669-75.

36. Elsasser-Beile U, Willenbacher W, Bartsch HH, et al. Cytokine production in leukocyte cultures during therapy with Echinacea extract. J Clin Lab Anal 1996;10:441-5.

37. Berman S, See DM, See JR, et al. Dramatic increase in immune mediated HIV killing activity induced by Echinacea angustifolia. Int Conf AIDS 1998;12:582 [abstract no. 32309].

38. Cho YK, Kim Y, Choi M, et al. The effect of red ginseng and zidovudine on HIV patients. Int Conf AIDS 1994;10:215 [abstract no. PB0289].

39. Kanter AS, Spencer DC, Steinberg MH, et al. Supplemental vitamin B and progression to AIDS and death in black South African patients infected with HIV. J Acquir Immune Defic Syndr 1999;21:252-3 [letter].

40. Butterworth RF, Gaudreau C, Vincelette J, et al. Thiamine deficiency in AIDS. Lancet 1991;338:1086.

41. Baum MK, Mantero-Atienza E, Shor-Posner G, et al. Association of vitamin B6 status with parameters of immune function in early HIV-1 infection. J Acquir Immune Defic Syndr 1991;4:1122-32.

42. Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency type 1 infection. Am J Epidemiol 1996;143:1244-56.

43. Boudes P, Zittoun J, Sobel A. Folate, vitamin B12, and HIV infection. Lancet 1990;335:1401-2.

44. Abdullah TH, Kirkpatrick DV, Carter J. Enhancement of natural killer cell activity in AIDS with garlic. Dtsch Zschr Onkol 1989;21:52-3.

45. Shoji S, Furuishi K, Yanase R, et al. Allyl compounds selectively killed human immunodeficiency virus (type 1)-infected cells. Biochem Biophys Res Commun 1993;194:610-21.

46. Robinson MK, Hong RW, Wilmore DW. Glutathione deficiency and HIV infection. Lancet 1992;339:1603-4.

47. Shabert JK, Wilmore DW. Glutamine deficiency as a cause of human immunodeficiency virus wasting. Med Hypotheses 1996;46:252-6.

48. Noyer CM, Simon D, Borczuk A, et al. A double-blind placebo-controlled pilot study of glutamine therapy for abnormal intestinal permeability in patients with AIDS. Am J Gastroenterol 1998;93:972-5 .

49. Shabert JK, Winslow C, Lacey JM, Wilmore DW. Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double-blind controlled trial. Nutrition 1999;15:860-4.

50. Castaldo A, Tarallo L, Palomba E, et al. Iron deficiency and intestinal malabsorption in HIV disease. J Pediatr Gastroenterol Nutr 1996;22:359-63.

51. Humbert JR, Moore LL. Iron deficiency and infection: a dilemma. J Pediatr Gastroenterol Nutr 1983;2:403-6.

52. Yamada Y, Nanba H, Kuroda H. Antitumor effect of orally administered extracts from fruit body of Grifola frondosa (maitake). Chemotherapy 1990;38:790-6.

53. Nanba H. Immunostimulant activity in vivo and anti-HIV activity in vitro of 3 branched b-1-6-glucans extracted from maitake mushrooms (Grifola frondosa). VIII International Conference on AIDS, Amsterdam, 1992 [abstract].

54. Muller F, Svardal AM, Aukrust P, et al. Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection. Am J Clin Nutr 1996;242-6.

55. Revillard JP. Lipid peroxidation in Human Immunodeficiency Virus infection. J Acquired Immunodef Synd 1992;5:637-8.

56. Singer P, Katz DP, Dillon L, et al. Nutritional aspects of the acquired immunodeficiency syndrome. Am J Gastroenterol 1992;87:265-73.

57. Tan SV, Guiloff RJ. Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS. J Neurol Neurosurg Psychiat 1998;65:23-8.

58. Keating JN, Trimble KC, Mulcahy F, et al. Evidence of brain methyltransferase inhibition and early brain involvement in HIV-positive patients. Lancet 1991;337:935-9.

59. Dorfman D, DiRocco A, Simpson D, et al. Oral methionine may improve neuropsychological function in patients with AIDS myelopathy: results of an open-label trial. AIDS 1997;11:1066-7.

60. Valesini G, Barnaba V, Benvenuto R, et al. A calf thymus lysate improves clinical symptoms and T-cell defects in the early stages of HIV infection: Second report. Eur J Cancer Clin Oncol 1987;23:1915-9.

61. Gorter R, Khwaja T, Linder M. Anti-HIV and immunomodulating activities of Viscum album (mistletoe). Int Conf AIDS 1992;8:84 [abstract no. PuB 7214].

62. Gorter R, Stoss M, el Arif N, et al. Immune modulating and anti-HIV activities of Viscum album (Iscador). Int Conf AIDS 1993;9:496 [abstract no. PO-B28-2167].

63. Cho YK, Kim Y, Choi M, et al. The effect of red ginseng and zidovudine on HIV patients. Int Conf AIDS 1994;10:215 [abstract no. PB0289].

64. Cho YK, Kim Y, Choi M, et al. The effect of red ginseng and zidovudine on HIV patients. Int Conf AIDS 1994;10:215 [abstract no. PB0289].

65. Inada Y, Watanabe K, Kamiyama M, et al. In vitro immunomodulatory effects of traditional Kampo medicine (sho-saiko-to: SST) on peripheral mononuclear cells in patients with AIDS. Biomed Pharmacother 1990;44:17-9.

66. Piras G, Makino M, Baba M. Sho-saiko-to, a traditional kampo medicine, enhances the anti-HIV-1 activity of lamivudine (3TC) in vitro. Microbiol Immunol 1997;41:835-9.

67. Fujimaki M, Hada M, Ikematsu S, et al. Clinical efficacy of two kinds of kampo medicine on HIV infected patients. Int Conf AIDS 1989;5:400 [abstract no. W.B.P.292].

68. Li BQ, Fu T, Yan YD, et al. Inhibition of HIV infection by baicalin—a flavonoid compound purified from Chinese herbal medicine. Cell Mol Biol Res 1993;39:119-24.

69. Markowitz JS, Donovan JL, DeVane CL, et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003;290:1500-4.

70. Cooper WC, James J. An observational study of the safety and efficacy of hypericin in HIV+ subjects. Int Conf AIDS 1990;6:369 [abstract no. 2063].

71. Steinbeck-Klose A, Wernet P. Successful long term treatment over 40 months of HIV-patients with intravenous hypericin. Int Conf AIDS 1993;9:470 [abstract no. PO-B26-2012].

72. Gulick RM, McAuliffe V, Holden-Wiltse J, et al. Phase I studies of hypericin, the active compound in St. John's wort, as an antiretroviral agent in HIV-infected adults. AIDS clinical trial group protocols 150 and 258. Ann Intern Med 1999;130:510-4.

73. Jandourek A, Vaishampayan JK, Vazquez JA. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. AIDS 1998;12:1033-7.

74. Valesini G, Barnaba V, Benvenuto R, et al. A calf thymus lysate improves clinical symptoms and T-cell defects in the early stages of HIV infection: Second report. Eur J Cancer Clin Oncol 1987;23:1915-9.

75. Copeland R, Baker D, Wilson H. Curcumin therapy in HIV-infected patients. Int Conf AIDS 1994;10:216 [abstract no. PB0876].

76. Hellinger JA, Cohen CJ, Dugan ME, et al. Phase I/II randomized, open-label study of oral curcumin safety, and antiviral effects on HIV-RT PCR in HIV+ individuals. 3rd Conf Retro and Opportun Infect 1996;Jan/Feb:78 [abstract].

77. Semba RD, Graham NMH, Caiaffa WT, et al. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med 1993;153:2149-54.

78. Semba RD, Miotti PG, Chiphangwi JD, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994;343:1593-7.

79. Coutsoudis A, Pillay K, Spooner E, et al. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group. AIDS 1999;13:1517-24.

80. Kennedy CM, Coutsoudis A, Kuhn L, et al. Randomized controlled trial assessing the effect of vitamin A supplementation on maternal morbidity during pregnancy and postpartum among HIV-infected women. J Acquir Immune Defic Syndr 2000;24:37-44.

81. Fawzi WW, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Defic Syndr 2000;23:246-54.

82. Coutsoudis A, Bobat RA, Coovadia HM, et al. The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women. Am J Public Health 1995;85:1076-81.

83. Hanekom WA, Yogev R, Heald LM, et al. Effect of vitamin A therapy on serologic responses and viral load changes after influenza vaccination in children infected with the human immunodeficiency virus. J Pediatr 2000;136:550-2.

84. Humphrey JH, Quinn T, Fine D, et al. Short-term effects of large-dose vitamin A supplementation on viral load and immune response in HIV-infected women. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:44-51.

85. Kanter AS, Spencer DC, Steinberg MH, et al. Supplemental vitamin B and progression to AIDS and death in black South African patients infected with HIV. J Acquir Immune Defic Syndr 1999;21:252-3 [letter].

86. Butterworth RF, Gaudreau C, Vincelette J, et al. Thiamine deficiency in AIDS. Lancet 1991;338:1086.

87. Baum MK, Mantero-Atienza E, Shor-Posner G, et al. Association of vitamin B6 status with parameters of immune function in early HIV-1 infection. J Acquir Immune Defic Syndr 1991;4:1122-32.

88. Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency type 1 infection. Am J Epidemiol 1996;143:1244-56.

89. Boudes P, Zittoun J, Sobel A. Folate, vitamin B12, and HIV infection. Lancet 1990;335:1401-2.

90. Kanter AS, Spencer DC, Steinberg MH, et al. Supplemental vitamin B and progression to AIDS and death in black South African patients infected with HIV. J Acquir Immune Defic Syndr 1999;21:252-3 [letter].

91. Butterworth RF, Gaudreau C, Vincelette J, et al. Thiamine deficiency in AIDS. Lancet 1991;338:1086.

92. Baum MK, Mantero-Atienza E, Shor-Posner G, et al. Association of vitamin B6 status with parameters of immune function in early HIV-1 infection. J Acquir Immune Defic Syndr 1991;4:1122-32.

93. Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency type 1 infection. Am J Epidemiol 1996;143:1244-56.

94. Boudes P, Zittoun J, Sobel A. Folate, vitamin B12, and HIV infection. Lancet 1990;335:1401-2.

95. Murray MF. Niacin as a potential AIDS preventive factor. Med Hypotheses 1999;53:375-9.

96. Murray MF, Srinivasan A. Nicotinamide inhibits HIV-1 in both acute and chronic in vitro infection. Biochem Biophys Res Commun 1995;210:954-9.

97. Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency type 1 infection. Am J Epidemiol 1996;143:1244-56.

98. Kanter AS, Spencer DC, Steinberg MH, et al. Supplemental vitamin B and progression to AIDS and death in black South African patients infected with HIV. J Acquir Immune Defic Syndr 1999;21:252-3 [letter].

99. Butterworth RF, Gaudreau C, Vincelette J, et al. Thiamine deficiency in AIDS. Lancet 1991;338:1086.

100. Baum MK, Mantero-Atienza E, Shor-Posner G, et al. Association of vitamin B6 status with parameters of immune function in early HIV-1 infection. J Acquir Immune Defic Syndr 1991;4:1122-32.

101. Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency type 1 infection. Am J Epidemiol 1996;143:1244-56.

102. Boudes P, Zittoun J, Sobel A. Folate, vitamin B12, and HIV infection. Lancet 1990;335:1401-2.

103. Gogu SR, Beckman BS, Rangan SR, Agrawal KC. Increased therapeutic efficacy of zidovudine in combination with vitamin E. Biochem Biophys Res Commun 1989;165:401-7.

104. Gogu SR, Agrawal KC. The protective role of zinc and N-acetylcysteine in modulating zidovudine induced hematopoietic toxicity. Life Sci 1996;59:1323-9.

105. Micke P, Beeh KM, Buhl R. Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients. Eur J Nutr 2002;41:12-8.

106. Wong KF, Middleton N, Montgomery M, et al. Immunostimulation of murine spleen cells by materials associated with bovine milk protein fractions. J Dairy Sci 1998;81:1825-32.

107. Minehira K, Inoue S, Nonaka M, et al. Effects of dietary protein type on oxidized cholesterol-induced alteration in age-related modulation of lipid metabolism and indices of immune function in rats. Biochim Biophys Acta 2000;1483:141-53.

108. Nellen H, Flores G, Wacher N. Treatment of human immunodeficiency virus enteropathy with a gluten-free diet. Arch Intern Med 2000;160:244 [letter].

109. Gibert CL, Wheeler DA, Collins G, et al. Randomized, controlled trial of caloric supplements in HIV infection. J Acquir Immune Defic Syndr 1999;22:253-9

110. Roubenoff R, McDermott A, Weiss L, et al. Short-term progressive resistance training increases strength and lean body mass in adults infected with human immunodeficiency virus. AIDS 1999;13:231-9.

111. Mustafa T, Sy FS, Macera CA, et al. Association between exercise and HIV disease progression in a cohort of homosexual men. Ann Epidemiol 1999;9:127-31.

Copyright © 2024 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. Self-treatment is not recommended for life-threatening conditions that require medical treatment under a doctor's care. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.

Log In

You need to log into the site to use this feature

Create A Free Account To Use Medicine Chest

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use Medicine Chest

Create A Free Account To Use this feature

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use this feature

You will be redirected to your program in 5 seconds.

Hi there.

Our Terms and Conditions and Privacy Policy have recently been updated.

Learn More


I Accept

By declining you will be logged out of your account

;